EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations
Authors:
Open Access
- 2 December 2021
- journal article
- letter
- Published by Springer Nature in Molecular Cancer
- Vol. 20 (1) , 1-7
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770179, 81830004, 82002144)
- public welfare scientific research project of Zhongshan City (2019B1015)
- clinical technological innovation project of Wuhan University (lcyf202010)
- Emergency Key Program of Guangzhou Laboratory (EKPG21-18)
This publication has 15 references indexed in Scilit:
- CRISPR/Cas Systems towards Next-Generation BiosensingTrends in Biotechnology, 2019
- Field-deployable viral diagnostics using CRISPR-Cas13Science, 2018
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience, 2018
- The emerging clinical relevance of genomics in cancer medicineNature Reviews Clinical Oncology, 2018
- Recombinase polymerase amplification: Basics, applications and recent advancesTrAC Trends in Analytical Chemistry, 2018
- Nucleic acid detection with CRISPR-Cas13a/C2c2Science, 2017
- Secondary mutations as mediators of resistance to targeted therapy in leukemiaBlood, 2015
- NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functionsBlood, 2013
- IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical PerspectivesClinical Cancer Research, 2012
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004